Abstract:
The present invention relates to an optically diffusing fiber probe, a method for manufacturing the same, and an application thereof. More specifically, the present invention relates to an optically diffusing fiber probe capable of emitting light in a plurality of directions and a method for manufacturing the same, hybrid optical medical equipment for both diagnosis and treatment of tubular human tissue, a catheter-based laser treatment device, and an electromagnetic energy application device for tubular tissue stricture, comprising the optically diffusing fiber probe.
Abstract:
A method for switching a memory resistance, including: changing a memory resistance of an oxide thin film of a semiconductor device by irradiating a near-infrared laser beam onto the oxide thin film, the semiconductor device having the oxide thin film formed on a substrate and two terminals formed at both ends of the oxide thin film.
Abstract:
Disclosed is an optical fiber pressure sensor including: a polarization beam splitter that splits input light from a broadband light source into two beams; a polarization controller through which vertically and horizontally polarized light coming out of the polarization beam splitter pass; a pressure chamber in which the polarization beam splitter and the polarization controller may be placed; and an optical spectrum analyzer into which vertically and horizontally polarized light passing through the polarization controller and getting out of the polarization beam splitter is introduced, wherein the pressure chamber includes a polarization-maintaining fiber and an optical fiber Bragg grating.
Abstract:
There is provided a pharmaceutical composition for preventing or treating human immunodeficiency virus, and more particularly, to a pharmaceutical composition and health functional food for preventing or treating/improving human immunodeficiency virus, the pharmaceutical composition and health functional food including a new compound with chitooligosaccharides conjugated amino acids or dipeptides as an effective component. The new compound has an excellent anti-HIV effect through an activity of inhibiting a HIV initial infection by interrupting an interaction between host-virus membranes, and also activities of inhibiting reverse transcriptase and protease of HIV. The compound according to the present invention is a conjugate synthesized through conjugating chitooligosaccharides derived from a natural material with amino acids or dipeptides. The compound is stable without cytotoxicity.
Abstract:
There is provided a composition including a veratric acid for preventing or treating inflammatory diseases. The veratric acid of the present invention has an excellent effect of inhibiting production of nitric oxide, an excellent activity of inhibiting production of IL-1β as a pro-inflammatory cytokine, and an excellent effect of inhibiting phosphorylation of MAPK, NF-κB, GSK-3β, and c-Raf in a macrophage cell stimulated by a stimulation factor that causes an inflammatory reaction. Thus, it can be used for development of medicines for treating inflammatory diseases which can be caused by excessive inflammatory reactions. Further, the veratric acid of the present invention does not induce toxicity to cells and is stable in the body. Thus, it can be used as a material of a health functional food capable of preventing or improving inflammatory diseases.
Abstract:
A driving device and a liquid injection device including the same are disclosed. A driving device according to an aspect may include a frame; a rotation shaft rotatably supported by the frame; a rotation driving unit configured to rotate the rotation shaft; a plurality of pinions configured to be spaced apart in the longitudinal direction of the rotation shaft and respectively coupled to the rotation shaft; and a plurality of racks configured to be engaged with the plurality of pinions, respectively and configured to move forward in a direction perpendicular to the longitudinal direction of the rotation shaft, wherein when the rotation shaft rotates, the engagement of the plurality of pinions and the plurality of racks that respectively correspond to each other is sequentially performed.
Abstract:
The present invention relates to a composition for the prevention or treatment of muscle diseases comprising a Sargassum serratifolium extract. The Sargassum serratifolium extract of the present invention has been found to protect muscle cells from dexamethasone-induced atrophy and muscle loss caused by the side effects of atorvastatin, inhibit the reduction in myotube diameter, suppress muscle atrophy, induce muscle hypertrophy, and inhibit muscle protein degradation. Additionally, in an animal model with dexamethasone-induced muscle atrophy, it was confirmed to increase muscle strength, improve muscle function, and increase muscle mass, making it useful for the prevention or treatment of muscle diseases.
Abstract:
A power generator is provided including a first outer case in which an internal space is formed; a first mainspring module having a first spring providing rotational force as it is wound and unwound; a first inner case which covers the first mainspring module and rotates about a rotation axis according to the rotational force provided by the first spring; a second outer case in which an internal space is formed and disposed on the first outer case; a second mainspring module having a second spring providing rotational force as it is wound and unwound; a second inner case which covers the second mainspring module and rotates about the rotation axis according to the rotational force provided by the second spring; and a first holder module coupled to the first outer case to limit the unwinding of the first spring until the unwinding of the second spring is completed.
Abstract:
The present disclosure provides a method and a device for decentralized edge computing. An edge device for implementing decentralized edge computing using a plurality of neural networks having a stacked architecture is provided, including an uncooperative unit configured to generate an initial decision using a neural network of zero-th layer that is a lowest layer of the stacked architecture, an adjacently cooperative unit configured to generate a first transmission messages and a first decision using a pair of neural networks of a first layer, and a network-wide cooperative unit configured to generate a second transmission messages and a second decision using a pair of neural networks of a second layer.
Abstract:
The present disclosure relates to a cervical body temperature change monitoring system and method, in which a cervical body temperature change can be monitored by measuring body temperatures of the cervical vertebra before and after treatment and analyzing the measurement results. A cervical body temperature change monitoring system may include: a cervical vertebral area processing unit that determines whether the cervical vertebra is recognized using at least one pressure sensor and performs segmentation on cervical vertebra recognition area to generate a plurality of segmented areas; a temperature distribution analysis unit that measures a body temperature in the cervical vertebra recognition area using at least one temperature sensor and generates a temperature distribution map; and a body temperature change measurement unit that derives a treatment effect by using the map.